ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag royal society disease medicine

Image of the tissue surrounding a pancreatic tumor thickening and scarring.
How Pancreas Injuries Can Cause Cancer in Mice
Dan Robitzski | Nov 9, 2021 | 4 min read
A key mutation turns healing cells into cancer promoters.
News in a nutshell
Megan Scudellari | Apr 25, 2010 | 2 min read
New Royal Society headlinkurl:Paul Nurse,;http://www.rockefeller.edu/research/faculty/abstract.php?id=316 Nobel Prize-winning cell biologist and president of Rockefeller University in New York City since 2003, has been linkurl:nominated;http://royalsociety.org/Sir-Paul-Nurse-nominated-as-next-President-of-the-Royal-Society/ by the Council of the Royal Society to lead the Royal Society in London. Following a vote of the Society's Fellows, the appointment will be confirmed in July. Paul NurseIma
Summer Science, British Style
Jef Akst and Richard P. Grant | Jul 8, 2011 | 7 min read
The Royal Society's annual science extravaganza packs some interesting stuff into 5 days of love and research.
3D image of a neuron cell network with a red glow representing inflammation.
New Insight into Brain Inflammation Inspires New Hope for Epilepsy Treatment 
Deanna MacNeil, PhD | Jun 1, 2023 | 2 min read
Clinicians and researchers teamed up to investigate how inappropriate proinflammatory mechanisms contribute to the pathogenesis of drug-refractory epilepsy.
a false color transmission electron microscope image of a neuronal cell body, with lysosomes colored dark green
Scientists Uncover Major Pathway Cells Use to Mend Leaky Lysosomes
Holly Barker, PhD | Oct 6, 2022 | 3 min read
Damaged lysosomes are repaired by a lipid-based signaling pathway dubbed PITT that could be targeted to treat neurodegenerative disease, its discoverers say.
Defining Rare Disorders: A Profile of Judith Hall
Anna Azvolinsky | Sep 1, 2019 | 8 min read
By bringing genetics into clinical medicine, the University of British Columbia medical geneticist helped to identify the gene mutations responsible for many rare diseases.
FDA Approves Gene Therapy for Spinal Muscular Atrophy
Ashley Yeager | May 27, 2019 | 3 min read
At $2 million for a single dose, Novartis’s Zolgensma is the most expensive medicine to date, but still less expensive over a lifetime than another approved drug for the rare genetic disease.
Illustration of scientists collaborating
How to Bring the Public into the Scientific Process
Amanda Heidt | Mar 14, 2022 | 10+ min read
A new wave of research is recruiting patients and other members of the public to serve as equal partners, bringing fresh perspectives to research on diseases and other conditions.
Deforestation Tied to Changes in Disease Dynamics
Katarina Zimmer | Jan 29, 2019 | 8 min read
Numerous studies link habitat destruction to malaria and other vector-borne diseases, but the relationship isn’t always clear.
Infectious Diseases Expert To Head National AIDS Unit
The Scientist Staff | Sep 17, 1989 | 5 min read
The National Institute of Allergy and Infectious Diseases has named George W. Counts as head of the newly established Clinical Research Management Branch in the Treatment Research Program of NIAID’s Division of AIDS. Prior to the appointment, Counts, 54, had been a professor of medicine at the University of Washington, Seattle, since 1975. He also served as director of the Clinical Microbiology Laboratory at the Fred Hutchinson Cancer Research Center in Seat- tle from 1985 to 1989. Co

Run a Search

ADVERTISEMENT